• Founded in 2015
  • Employees: 130

Description :

Autolus is focused on the development and commercialisation of engineered T-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers.

Headquarters :

Autolus Limited c/o Syncona Partners 215 Euston Road London

Related Posts

We use cookies to give you the best experience and for advertising purposes. By accepting, you support our independent media and its' freely accessible content.